Problem
Pharmaceutical client could not obtain desired compound for preclinical work
Three different contractors tried to synthesize over a two-year period
Solution
Drug Discovery Alliances selected the appropriate partner to make desired compound for pre-IND needs and Phase-1 clinical trials
The CRO partner is the global leader in process chemistry with a staff comprised of entirely PhD process chemists with decades of pharmaceutical experie
Outcome
$300 million dollars was realized by client who licensed this asset to a pharmaceutical company
$1 billion dollars in potential down-stream revenues